Inidascamine

AssetAlso RL-007

Stage
Human trials
Modality
Small molecule
Target
Not known
1
Indication
0
Trials
1
Developer

Indications

1
  • Cognitive impairment associated with schizophrenia

    Human trials, prnewswire.com, 7 Oct 2026

In the full profile

  • Owner and partners2
  • Signals1

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets